Health Care & Life Sciences » Biotechnology | China Regenerative Medicine International Ltd.

China Regenerative Medicine International Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
272
119
1,032
1,860
377
708
Total Accounts Receivable
11
36
120
73
440
24
Inventories
1
2
5
9
29
32
Other Current Assets
24
20
32
52
331
102
Total Current Assets
307
177
1,188
1,994
1,176
867
Net Property, Plant & Equipment
131
141
175
191
295
105
Total Investments and Advances
4
-
-
-
1,273
190
Long-Term Note Receivable
-
-
15
28
33
-
Intangible Assets
306
638
672
683
647
112
Other Assets
5
5
5
5
104
150
Total Assets
753
961
2,055
2,901
3,528
1,423
ST Debt & Current Portion LT Debt
43
38
59
543
-
Accounts Payable
1
1
1
2
238
Income Tax Payable
-
-
-
9
3
Other Current Liabilities
59
53
57
139
520
Total Current Liabilities
103
92
118
693
762
Long-Term Debt
-
-
6
-
772
Deferred Taxes
19
90
87
90
81
Other Liabilities
-
-
-
-
100
Total Liabilities
122
181
211
783
1,715
Common Equity (Total)
622
777
1,803
2,066
1,760
Total Shareholders' Equity
622
777
1,803
2,066
1,760
Total Equity
631
780
1,844
2,118
1,813
Liabilities & Shareholders' Equity
753
961
2,055
2,901
3,528
Accumulated Minority Interest
8
3
41
52
53

About China Regenerative Medicine International

View Profile
Address
Rooms 3006-10, 30/F
Hong Kong
Hong Kong
Employees -
Website http://www.crmi.hk
Updated 07/08/2019
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development, production and sales of tissue engineering and regenerative medicine products. It operates through the following business segments: Tissue Engineering, Cell, and Cosmetic and Others, and Medical Equipment. The Tissue Engineering segment produces and sells tissue.